Jn. Lorenz et al., REGULATION OF CALCIUM-CHANNEL CURRENT IN A7R5 VASCULAR SMOOTH-MUSCLE CELLS BY CYCLIC-NUCLEOTIDES, The American journal of physiology, 266(6), 1994, pp. 30001656-30001663
In vascular smooth muscle (VSM) cells, the slow inward calcium current
(I-Ca) may be regulated by phosphorylation of the calcium channel pro
tein or of associated regulatory proteins. We investigated the role of
several protein kinase systems in the regulation of I-Ca in cultured
A7r5 cells, a clonal cell line derived from rat aorta. The perforated-
patch voltage-clamp technique was used to record whole cell I-Ca. To i
solate the I-Ca, the pipette contained high Cs+ and the bath contained
140 mM tetraethylammonium to block potassium currents. Ba2+ was used
as the charge carrier. In control experiments, I-Ca was stable for at
least 15 min. Compared with 23 +/- 3% in the time-control group (i.e.,
run-down; n = 10), 3 mM 8-bromoadenosine 3',5'-cyclic monophosphate (
8-BrcAMP) inhibited peak I-Ca by 53 +/- 3% (n = 9) within 15 min. Simi
larly, 3 mM 8-bromo-guanosine 3',5'-cyclic monophosphate (8-BrcGMP) in
hibited I-Ca by 59 +/- 4 (n = 11). Application of 30 mu M forskolin in
hibited I-Ca by 58 +/- 9% (n = 6) within 5 min (compared with 4 +/- 3%
for the 5-min time control). Forskolin also shifted the reversal pote
ntial to the left, suggesting a stimulation of an outward current. In
the presence of the protein kinase inhibitor, 1-(5-isoquinolinylsulfon
yl)-2-methylpiperazine, the same dose of forskolin had no effect (n =
7). The water-soluble analogue of forskolin (L-858051, 30 mu M) decrea
sed I-Ca by 72 +/- 11% (n = 9) and reduced the outward current compone
nt. These results suggest that, in A7r5 cells, cAMP and cGMP both modu
late whole cell I-Ca, and the data are consistent with a phosphorylati
on-dependent mechanism. The observed inhibition of I-Ca by the cyclic
nucleotides presumably lowers calcium influx and cell excitability and
therefore causes vasodilation. Thus channel phosphorylation may be an
important mechanism for the cyclic nucleotide-dependent actions of so
me vasodilators.